Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: J Vasc Surg. 2021 Oct 23;75(4):1211–1222.e1. doi: 10.1016/j.jvs.2021.10.019

Table II.

Unadjusted Analysis: Clinical Characteristics and Growth Rate

Clinical Characteristic AAA Growth Rate without Clinical Characteristic (cm/yr) Change in Growth Rate with Clinical Characteristic (cm/yr) Clinical Characteristic*time
p-value
Randomized Doxycycline Rx   0.19   0.01   0.43
Diabetes   0.21 −0.06 <0.0001
Female sex   0.21 −0.02   0.01
Smoking current   0.19   0.05   0.0001
Smoking former   0.19 −0.02   0.66
COPD   0.19   0.00   0.24
ARB therapy   0.20 −0.06 <0.0001
Statin therapy   0.22 −0.03 <0.0001
Beta blocker therapy   0.20 −0.01   0.22
BMI (per kg/m2) −0.0019 <0.01

Unadjusted associations of clinical characteristics and the AAA growth rate in the N-TA3CT. Mean growth rates as calculated by linear regression. P-values presented for each clinical characteristic are derived from a linear mixed effects model on AAA growth. BMI is treated as a continuous variable – the effect on the AAA growth is presented as a linear coefficient.